Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
BMC Cancer|February 9, 2024
Impact of preoperative transcatheter arterial chemoembolization (TACE) on postoperative long-term survival in patients with nonsmall hepatocellular carcinoma: a propensity score matching analysisRun Hu, Jie Xu, Hongxiang Wang, et al.
International Journal of Surgery (London, England)|January 22, 2026
Multi-omics analysis identifies TBCB as a therapeutic target in sepsis-induced liver injuryXiang Ma, Zhenxiang Peng, Kai Lei, et al.
Cancer Cell International|November 27, 2025
Hsa-miR-423-5p selectively loaded in hypoxic exosomes reduces the sensitivity of normoxic hepatocellular carcinoma to sorafenib via autophagyBian Shu, Min Zou, Rui Liao, et al.
Langenbeck'S Archives of Surgery|February 6, 2024
Extended lymphadenectomy based on the TRIANGLE for pancreatic head cancer: a single-center experienceKai Lei, Jiaguo Wang, Xingxing Wang, et al.
Molecular Immunology|October 15, 2025
Role of efferocytosis in liver transplantation via hepatic macrophageMinjie Zhao, Xuesong Xu, Haiyang Peng, et al.
Scientific Reports|October 22, 2016
Monoacylglycerol Lipase: A Novel Potential Therapeutic Target and Prognostic Indicator for Hepatocellular CarcinomaJunyong Zhang, Zuojin Liu, Zhengrong Lian, et al.
Journal of Cancer Research and Clinical Oncology|August 16, 2023
A novel nomogram based on the hematological prognosis risk scoring system can predict the overall survival of patients with hepatocellular carcinomaKai Lei, Zhuofan Deng, Jiaguo Wang, et al.
Biochemical and Biophysical Research Communications|March 3, 2026
Sirt1-eIF2α axis drives pro-inflammatory macrophage activation through ER stress aggravating liver IRI in aged miceYun Zhou, Xinglang Wu, Xuesong Xu, et al.
The Journal of Surgical Research|July 11, 2009
Knockdown of interleukin-2 by shRNA-mediated RNA interference prolongs liver allograft survivalYong Chen, Tao Yan, Liu-jun Shi, et al.
Journal of Medical Virology|December 26, 2022
Risk of waning humoral responses after inactivated or subunit recombinant SARS-CoV-2 vaccination in patients with chronic diseases: Findings from a prospective observational study in ChinaHu Li, Dachuan Cai, Depeng Jiang, et al.
Pageof 7